Characteristics of ototoxicity of aminoglycosides "locked" to prevent hemodialysis catheter-related infections
- 1 January 2006
- journal article
- Published by Wiley in Hemodialysis International
- Vol. 10 (1) , 94
- https://doi.org/10.1111/j.1542-4758.2006.01181.x
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Locking hemodialysis catheters with cefotaxime instead of gentamicin to avoid potential ototoxicityKidney International, 2005
- Prospective study of gentamicin locking of tunnelled dialysis catheters: the effect on infection rates and CRP.Kidney International, 2005
- Locking of tunneled hemodialysis catheters with gentamicin and heparinKidney International, 2004
- Ototoxicity from the Aminoglycoside-Heparin/Citrate Locks Applied for the Prevention of Hemodialysis Catheter-Related InfectionsThe Journal of Vascular Access, 2003
- Sudden Irreversible Sensory-Neural Hearing Loss in a Patient with Diabetes Receiving Amikacin as an Antibiotic-Heparin LockPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2002
- N–Methyl–D–aspartate antagonists limit aminoglycoside antibiotic–induced hearing lossNature Medicine, 1996
- Delay in Hearing Loss Following Drug AdministrationActa Oto-Laryngologica, 1990